Regenex Pharmaceutical China
Shanghai, China· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A regenerative medicine company developing stem cell therapies for tissue repair and degenerative diseases.
Regenerative MedicineOrthopedicsAutoimmune
Technology Platform
A standardized platform for manufacturing clinical-grade, allogeneic mesenchymal stem cells (MSCs) with defined potency assays.
Opportunities
China's growing acceptance of regenerative therapies and large patient base with degenerative diseases create a substantial market.
Risk Factors
Evolving and sometimes ambiguous regulations for cell therapies in China pose significant approval and commercialization risks.
Competitive Landscape
Leads a fragmented field of Chinese stem cell therapy companies but faces competition from new biologic drugs for similar indications.